(682) 651-1112
(682) 651-1112
Evidentis Clinical Research is a specialty research center focused on advancing liver, metabolic, and cardiometabolic health. We conduct Phase 1-4 clinical trials that generate high-quality data, support therapeutic development, and expand access to innovative investigational treatments. Our model integrates subspecialty medical expertise with disciplined operational systems in a controlled research environment capable of supporting complex and time-sensitive protocols.
Evidentis conducts clinical trials across key therapeutic domains:
Liver disease, including MASLD, ALD, metALD, AUD, viral hepatitis, fibrosis, cirrhosis and autoimmune / cholestatic conditions (AIH, PBC, PSC)
Metabolic health, including obesity, insulin resistance, dyslipidemia and broader metabolic dysfunction
Cardiometabolic disease, including hypertension, cardiovascular risk factors and vascular-metabolic risk pathways
Immunology and inflammation relevant to liver and metabolic conditions
Pharmacokinetic and early-phase research, including extended sampling protocols conducted within a dedicated overnight research setting
Studies are overseen by a triple board-certified transplant hepatologist with additional training in obesity medicine, ensuring academic-level clinical oversight within a streamlined, decision-efficient research structure. Sponsors benefit from direct investigator accessibility, efficient feasibility alignment, flexible scheduling, including overnight protocols when required, and disciplined protocol execution without institutional delay.
Our facility is purpose-built to support precise clinical research execution. The environment accommodates structured PK/PD workflows, secure investigational product handling, temperature-controlled laboratory systems, and GCP-aligned digital processes through CRIO CTMS. Integrated data oversight and auditable chain-of-custody systems support consistent performance, participant safety, and data integrity across complex clinical trial protocols.
Evidentis delivers clear communication, efficient scheduling, and streamlined visit flow. Participants receive clinically informed guidance within a safe, organized research environment from screening through follow-up.
Our recruitment ecosystem draws from:
Evidentis conducts all studies in accordance with Good Clinical Practice (GCP) and maintains IRB oversight for every protocol.
Participants undergo a thorough informed consent process led by qualified clinical staff. Study procedures follow established SOPs governing participant safety, investigational product management, temperature-controlled sample handling, and data integrity.
Ongoing staff training, internal oversight processes, and audit readiness support consistent regulatory compliance and participant protection.
To conduct rigorous, ethically grounded clinical research that advances therapies in liver, metabolic, and cardiometabolic disease, delivered with scientific integrity, operational precision, and disciplined execution.
To be recognized as a leading specialty research center known for efficient trial delivery and meaningful contributions to therapeutic development in liver and metabolic health.
Evidentis is derived from the Latin word evidens, meaning clear or plainly shown. The name reflects our mission to generate clinical data that are transparent, rigorous, and reproducible, evidence that is clearly demonstrated and scientifically credible.
The Evidentis logo uses a magnifying glass surrounding the letter ‘E’ to represent careful examination, clarity and scientific focus. The medical cross in the upper corner highlights our grounding in clinical research and participant care. The design reflects a research organization built on precision, transparency and purpose.